EGFR and neoplasm: In tumor cell lines, the loss of FLCN resulted in slower endocytic trafficking of EGFR by decreased Rab7A GTP-to-GDP turnover, resulting in prolonged and elevated phosphorylated EGFR and downstream signaling (76).